Tissue‐Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma
Journal of Extracellular Vesicles · 2026-02 · 15 (2)
DOI: 10.1002/jev2.70221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 08.02.2026. Verfasst von Xinrui Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Extracellular Vesicles, Biomarkers, Tumor, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghal High level Local universities Construction Program, Shanghai Top Priority Research Center Project, Shanghai Rising-Star Program.
Abstract (Originalsprache)
Tissue‐derived extracellular vesicles (Ti‐EVs) play a crucial role in tumour progression, but their value as differential diagnostic markers for various renal cell carcinoma (RCC) subtypes remains uncertain. Through analysis of paired tumour and normal tissues, along with their corresponding Ti‐EVs, we identified NEAT1 and MMP15 as markers for papillary RCC (pRCC); DSG2 and AC026888.1 for chromophobe RCC (chRCC); NDUFA4L2, SERPINA1, VEGFA, EGLN3, CPE and C6orf223 for low‐grade clear cell RCC (low‐grade ccRCC); and NDUFA4L2, APOC1, TGFBI and LINC00887 for high‐grade ccRCC (high‐grade ccRCC). In an external validation cohort, an area under the curve (AUC) of 0.922 for low‐grade ccRCC detection and 0.874 for high‐grade ccRCC detection was achieved, respectively, using urinary EVs. Furthermore, integrating single‐cell sequencing data revealed that SERPINA1 and VEGFA in low‐grade ccRCC, and APOC1 and TGFBI in high‐grade ccRCC, were derived from tumour‐associated macrophages, whereas NDUFA4L2 originated from cancer cells in both low‐ and high‐grade ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute of Urological Diseases, Nantong First People's Hospital, Nantong University, Nantong, China.
ORCID-Profile: Xinrui Wu, Xingang Cui
Förderung
- Shanghal High level Local universities Construction Program
- Shanghai Top Priority Research Center Project
- Shanghai Rising-Star Program
- Shanghai Municipal Health Commission
- Physician-Scientist Development Award from Shanghai Immune Therapy Institute
- Shanghai Professional Technical Service Platform
- Shanghai Jiao Tong University School of Medicine Institute of Molecular Medicine Clinical+ Excellence Program
- Shanghai Jiao Tong University
Zitieren
APA
Wu, X., Zhou, J., Jiang, C., Chen, W., Peng, Z., Wu, T., Ge, Y., Du, X., Hu, C., Wu, X., Huang, J., Zhang, J., Cui, X., Xue, W., Chen, Y., & Dong, L. (2026). Tissue‐Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma. Journal of Extracellular Vesicles, 15(2). https://doi.org/10.1002/jev2.70221
Vancouver
Wu X, Zhou J, Jiang C, Chen W, Peng Z, Wu T, et al. Tissue‐Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma. Journal of Extracellular Vesicles. 2026;15(2). doi:10.1002/jev2.70221
BibTeX
@article{Wu2026,
author = {Wu, Xinrui and Zhou, Jiale and Jiang, Chen and Chen, Wenjin and Peng, Zehong and Wu, Tianyang and Ge, Yang and Du, Xinxing and Hu, Cong and Wu, Xiaorong and Huang, Jiwei and Zhang, Jin and Cui, Xingang and Xue, Wei and Chen, Yonghui and Dong, Liang},
title = {Tissue‐Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {2},
doi = {10.1002/jev2.70221}
}
EUVIMED